RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Rock Springs Capital
R

Rock Springs Capital portfolio

Rock Springs Capital has 8 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Institutional investor.
Portfolio on Recent Funding: 8.
Deals, last 12 months: 2.
Capital in their rounds: $1.33B.
Latest deal: Abcuro · Aug 18, 2026.
About this page

It is an institutional investor based in Baltimore, US, founded in 2013. Its most recent investment on record is Abcuro's $66M Series B+ round in August 2026, alongside Redmile Group, NEA, Samsara Biocapital and 6 others. By category, its portfolio leans toward Health and bio (8) and Logistics and mobility (1). It has co-invested with Casdin Capital, ARCH Venture Partners and RA Capital Management, most often Casdin Capital (4 rounds).

About Rock Springs Capital

Firm type: Institutional investor.
Headquarters: Baltimore, US.
Founded: 2013.
Stages: Late Stage.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices.

What Rock Springs Capital invests in

Rock Springs Capital recent investments

How Rock Springs Capital invests

StageDealsCapital in rounds
Series B+ 7 64%$643.5M
Series A 4 36%$682M
YearDealsCapital in rounds
2020 1 9%$86M
2021 3 27%$208M
2022 2 18%$411M
2024 2 18%$255M
2025 1 9%$200M
2026 2 18%$165.5M

Rock Springs Capital portfolio companies

CompanyRound with Rock Springs CapitalTotal raisedLatest raise
AAbcuro
Health and bio
Series B+ · $66M$463MAug 18, 2026
Series B+
CCity Therapeutics
Health and bio
Series B+ · $99.5M$234.5MAug 8, 2026
Series B+
TTreeline Biosciences
Health and bio
Series A · $200M$461MSep 3, 2025
Series A
IIDRx
Health and bio
Series B+ · $120M$242MAug 8, 2024
Series B+
MMOMA Therapeutics
Health and bio
Series B+ · $150M$236MMay 10, 2022
Series B+
VVedanta Biosciences
Health and bio
Series B+$166.5MAug 6, 2026
round
SSynthekine
Health and bio
Series B+ · $108M$290MJan 6, 2023
Series B+
PPersonal Genome Diagnostics
Health and bio
Series B+ · $100M$123.8MNov 24, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 11 rounds on Recent Funding that name Rock Springs Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Rock Springs Capital, which is a subset of its real portfolio. API: /api/v1/investors/rock-springs-capital (get a free API key). More: the most active VC firms and new venture capital funds.